Table 2 Numbers of strategies provided in brainstorm phases and structured phase
Brainstorm phases | Structured phase | |||||
|---|---|---|---|---|---|---|
Number of crude and unique strategiesc | Crude number of strategies | Unique strategies within this group and phase | Additional unique strategies suggested in structured phase compared to brainstorm phase per group (% of all unique strategies in structured phase) | Total of unique strategies per group per country | ||
Healthcare researchers | Germany | 38 | 8 | 8 | 7 (88%) | 45 |
Netherlands | 20 | 28 | 14 | 12 (86%) | 32 | |
Norway | 35 | - | - | - | 35 | |
Poland | 18 | 17 | 17 | 0 (0%) | 18 | |
UK | 49 | 16 | 16 | 8 (50%) | 57 | |
Quality improvement officers | Germany | 33 | 5 | 5 | 4 (80%) | 37 |
Netherlands | 19 | 27 | 27 | 27 (100%) | 46 | |
Norway | 99 | - | - | - | 99 | |
Polanda | 21 | 21 | 21 | 0 (0%) | 21 | |
UK | 22 | 7 | 7 | 7 (100%) | 29 | |
Healthcare professionals | Germany | 21 | 12 | 12 | 12 (100%) | 33 |
Netherlandsb | 36 | 76 | 55 | 55 (100%) | 91 | |
Norwayb | 120 | - | - | - | 12 | |
Poland | 8 | 8 | 8 | 0 (0%) | 8 | |
UKb | 81 | 23 | 23 | 23 (100%) | 104 | |
Authorities, health insurers, and other purchasers of healthcare | Germany | 32 | 9 | 9 | 9 (100%) | 41 |
Netherlands | 24 | 35 | 22 | 22 (100%) | 46 | |
Norway | 93 | - | - | - | 93 | |
Poland | 13 | 14 | 13 | 1 (7%) | 14 | |
UK | 28 | 13 | 13 | 3 (23%) | 31 | |
Patients and relatives of patients | Netherlandsb | 36 | 42 | 37 | 35 (95%) | 71 |
Norway | 35 | - | - | - | 35 | |
Total | 881 | 361 | 307 | 225 | 1106 | |